Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?

Aydemir, Selim; Aksakal, Emrah; Aydinyilmaz, Faruk; Gulcu, Oktay; Sarac, İbrahim; Aydin, Sidar; Dogan, Remziye; Lazoglu, Merve; Kalkan, Kamuran

doi:10.1186/s43044-022-00291-9

Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?

Aydemir S., Aksakal E., Aydinyilmaz F., Gulcu O., Sarac I., Aydin S. Ş., ...Daha Fazla

EGYPTIAN HEART JOURNAL, cilt.74, sa.1, 2022 (ESCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 74 Sayı: 1
Basım Tarihi: 2022
Doi Numarası: 10.1186/s43044-022-00291-9
Dergi Adı: EGYPTIAN HEART JOURNAL
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, Directory of Open Access Journals
Anahtar Kelimeler: COVID-19, Atrial fibrillation, Mortality
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Atatürk Üniversitesi Adresli: Evet

Özet

Background: Coronavirus Disease-2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2, still remains prevalent and severe. We aimed to evaluate the effects of pre-existing atrial fibrillation and new-onset atrial fibrillation (NOAF) on the clinical severity and mortality of COVID-19.